AU2001281136A1 - Detection and diagnosis of smoking related cancers - Google Patents

Detection and diagnosis of smoking related cancers

Info

Publication number
AU2001281136A1
AU2001281136A1 AU2001281136A AU8113601A AU2001281136A1 AU 2001281136 A1 AU2001281136 A1 AU 2001281136A1 AU 2001281136 A AU2001281136 A AU 2001281136A AU 8113601 A AU8113601 A AU 8113601A AU 2001281136 A1 AU2001281136 A1 AU 2001281136A1
Authority
AU
Australia
Prior art keywords
diagnosis
detection
related cancers
smoking related
smoking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281136A
Inventor
Feng Jiang
Ruth Katz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU2001281136A1 publication Critical patent/AU2001281136A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001281136A 2000-08-04 2001-08-06 Detection and diagnosis of smoking related cancers Abandoned AU2001281136A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22281100P 2000-08-04 2000-08-04
US60/222,811 2000-08-04
PCT/US2001/024718 WO2002012563A2 (en) 2000-08-04 2001-08-06 Detection and diagnosis of smoking related cancers

Publications (1)

Publication Number Publication Date
AU2001281136A1 true AU2001281136A1 (en) 2002-02-18

Family

ID=22833787

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281136A Abandoned AU2001281136A1 (en) 2000-08-04 2001-08-06 Detection and diagnosis of smoking related cancers

Country Status (3)

Country Link
US (3) US6797471B2 (en)
AU (1) AU2001281136A1 (en)
WO (1) WO2002012563A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001281136A1 (en) * 2000-08-04 2002-02-18 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
US20040181344A1 (en) * 2002-01-29 2004-09-16 Massachusetts Institute Of Technology Systems and methods for providing diagnostic services
WO2004099442A2 (en) * 2003-05-06 2004-11-18 University Hospital Of Basel Kcnma1 as a therapeutic target in cancer treatment
EP2290071B1 (en) 2004-05-28 2014-12-31 Asuragen, Inc. Methods and compositions involving microRNA
PL2302055T3 (en) 2004-11-12 2015-02-27 Asuragen Inc Methods and compositions involving miRNA and miRNA inhibitor molecules
EP3770278A1 (en) * 2005-04-14 2021-01-27 The Trustees of Boston University Diagnostic for lung disorders using class prediction
US7660468B2 (en) * 2005-05-09 2010-02-09 Like.Com System and method for enabling image searching using manual enrichment, classification, and/or segmentation
US20070178503A1 (en) * 2005-12-19 2007-08-02 Feng Jiang In-situ genomic DNA chip for detection of cancer
US20070218480A1 (en) * 2006-01-25 2007-09-20 The Board Of Regents Of The University Of Texas System Detection and diagnosis of smoking related cancers
EP2605018A1 (en) 2006-03-09 2013-06-19 The Trustees of the Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
WO2008036765A2 (en) * 2006-09-19 2008-03-27 Asuragen, Inc. Micrornas differentially expressed in pancreatic diseases and uses thereof
US20100291569A1 (en) * 2006-11-30 2010-11-18 Abbott Laboratories Assay for prediction of response to met antagonists
US20090023138A1 (en) * 2007-07-17 2009-01-22 Zila Biotechnology, Inc. Oral cancer markers and their detection
US8361714B2 (en) 2007-09-14 2013-01-29 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
EP2193211A4 (en) 2007-09-19 2010-12-08 Univ Boston Identification of novel pathways for drug development for lung disease
WO2009047756A2 (en) * 2007-10-11 2009-04-16 Bioview Ltd. Methods and kits for diagnosing lung cancer
US8071562B2 (en) 2007-12-01 2011-12-06 Mirna Therapeutics, Inc. MiR-124 regulated genes and pathways as targets for therapeutic intervention
WO2009126153A1 (en) * 2008-04-09 2009-10-15 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Telomerase suppressor (lela1) compositions and methods for diagnosis and treatment of cancer in a mammalian subject
WO2009137807A2 (en) 2008-05-08 2009-11-12 Asuragen, Inc. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
US8785131B2 (en) * 2008-11-11 2014-07-22 Abbott Laboratories Prognostic test for early stage non small cell lung cancer (NSCLC)
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
CN106399506A (en) 2009-10-26 2017-02-15 雅培分子公司 Diagnostic methods for determining prognosis of non-small cell lung cancer
EP2494076B1 (en) * 2009-10-26 2017-11-22 Abbott Molecular Inc. Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancer
WO2012075136A2 (en) * 2010-11-30 2012-06-07 Fox Chase Cancer Center Targeting of cyp1b1 in the treatment of head and neck cancer and lung cancer
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
US10023855B2 (en) 2011-10-31 2018-07-17 Macrogen, Inc. Fusion protein comprising C-terminal domain of RET protein and use thereof as a diagnosing marker
WO2013167387A1 (en) * 2012-05-10 2013-11-14 Ventana Medical Systems, Inc. Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2
JP2016513794A (en) * 2013-03-06 2016-05-16 ゼネラル・エレクトリック・カンパニイ Method for analyzing H & E stained biological sample
EP3626308A1 (en) 2013-03-14 2020-03-25 Veracyte, Inc. Methods for evaluating copd status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
JP7356788B2 (en) 2014-11-05 2023-10-05 ベラサイト インコーポレイテッド Systems and methods for diagnosing idiopathic pulmonary fibrosis in transbronchial biopsies using machine learning and high-dimensional transcriptional data
US20180127829A1 (en) * 2014-12-10 2018-05-10 Board Of Regents, The University Of Texas System Circulating tumor and tumor stem cell detection using genomic specific probes
US10927417B2 (en) 2016-07-08 2021-02-23 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
WO2019005762A1 (en) * 2017-06-26 2019-01-03 Abbvie Inc. Treatment of non-small cell lung cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475720B1 (en) 1986-01-16 2002-11-05 The Regents Of The University Of California Chromosome-specific staining to detect genetic rearrangements associated with chromosome 3 and/or chromosome 17
US6344315B1 (en) 1986-01-16 2002-02-05 The Regents Of The University Of California Chromosome-specific staining to detect genetic rearrangements associated with chromosome 3 and/or chromosome 17
US5670314A (en) * 1994-02-22 1997-09-23 Regents Of The University Of California Genetic alterations that correlate with lung carcinomas
US6689561B1 (en) 1994-04-14 2004-02-10 The Regents Of The University Of California Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
US20020137030A1 (en) 1995-06-30 2002-09-26 John Hopkins University School Of Medicine Method of detection of neoplastic cells
WO1998008980A1 (en) 1996-08-28 1998-03-05 The Johns Hopkins University School Of Medicine Method for detecting cell proliferative disorders
US20030138928A1 (en) 1997-08-26 2003-07-24 Carson Dennis A. Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
US6576420B1 (en) 1998-06-23 2003-06-10 Regents Of The University Of California Method for early diagnosis of, and determination of prognosis in, cancer
US6174681B1 (en) 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer
CN1297905A (en) * 1999-11-24 2001-06-06 上海博容基因开发有限公司 Human ribosomal protein L14.22 as one new kind of polypeptide and polynuceotides encoding this polypeptide
US6774226B1 (en) 1999-11-30 2004-08-10 Ludwig Institute For Cancer Research Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
AU2001281136A1 (en) * 2000-08-04 2002-02-18 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
JP2004518437A (en) 2000-10-25 2004-06-24 ディアデクサス インコーポレーテッド Compositions and methods for lung-specific genes and proteins
US7027658B2 (en) * 2000-12-20 2006-04-11 Level Set Systems, Inc. System for geometrically accurate compression and decompression
JP4251437B2 (en) 2001-02-20 2009-04-08 バイシス・インコーポレーテツド Methods and probes for detection of cancer
US20030119080A1 (en) 2001-10-15 2003-06-26 Mangano Joseph A. Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells

Also Published As

Publication number Publication date
US7741034B2 (en) 2010-06-22
US8093001B2 (en) 2012-01-10
US20100240060A1 (en) 2010-09-23
US6797471B2 (en) 2004-09-28
US20060078885A1 (en) 2006-04-13
WO2002012563A2 (en) 2002-02-14
WO2002012563A3 (en) 2003-08-07
US20020081612A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
AU2001281136A1 (en) Detection and diagnosis of smoking related cancers
EP1187075B8 (en) Human body detector
AU7593001A (en) Alpha-msh related compounds and methods of use
AU2001288762A1 (en) Detection and characterization of microorganisms
AU2002221109A1 (en) Body impedance measuring instrument
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2001288249A1 (en) Biosensors and methods for their use
AUPP974599A0 (en) Detection and classification of breathing patterns
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001263224A1 (en) Multi-functional smoke detector and signal device
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2001239948A1 (en) Integrated probe and sensor system
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU2002306991A1 (en) Detection and amplification of ligands
AU2001249444A1 (en) Methods and compositions for the simultaneous detection of multiple analytes
AU2001241877A1 (en) Methods for detection and treatment of neural cancers
AU2001247196A1 (en) Methods and compositions for detection of disease
AU2002341577A1 (en) Rapid and specific detection of campylobacter
EP1212600A4 (en) Methylene blue diagnostic agent and diagnostic methods for detection of epithelial cancer
AU2002327639A1 (en) Detection and treatment of cancers of breast
GB0018050D0 (en) Detection of human papillomavirus mRNA
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001268236A1 (en) Use of aicar and related compounds
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof